ATC Group: C03BA Sulfonamides, plain

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C03BA in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C03 Diuretics
3 C03B Low-ceiling diuretics, excl. thiazides
4 C03BA Sulfonamides, plain

Group C03BA contents

Code Title
C03BA02 Quinethazone
C03BA03 Clopamide
C03BA04 Chlorthalidone
C03BA05 Mefruside
C03BA07 Clofenamide
C03BA08 Metolazone
C03BA09 Meticrane
C03BA10 Xipamide
C03BA11 Indapamide
C03BA12 Clorexolone
C03BA13 Fenquizone
C03BA82 Clorexolone, comb. with psycholeptics

Active ingredients in C03BA

Active Ingredient

Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action.

Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action.

Metolazone is a diuretic antihypertensive drug for the treatment of edema. Metolazone is a quinazoline diuretic, with properties generally similar to the thiazide diuretics. The actions of metolazone result from interference with the renal tubular mechanism of electrolyte reabsorption.

Xipamide is an anti-hypertensive diuretic which can be characterised pharmacologically neither as a thiazide nor as a specific loop diuretic. Although structurally similar to chlorthalidone, it has a markedly different pharmacological profile with its main diuretic effect exerted at the distal section of the nephron.

Related product monographs

Document Type Information Source  
 DIUREXAN Tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 FRUMERON Coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 HYGROTON Tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 NATRILIX Prolonged-release tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ZAROXOLYN Tablet MPI, EU: SmPC Health Products and Food Branch (CA)